Tibet AIM Pharm. Inc. (SHE:002826)
China · Delayed Price · Currency is CNY 14.93
-0.45 (-2.93%)
Nov 13, 2026, 3:04 PM CST
Tibet AIM Pharm. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 423.88 | 537.66 | 427.4 | 385.86 | 321.28 | 182.73 |
Trading Asset Securities | 300 | - | - | - | - | - |
Cash & Short-Term Investments | 723.88 | 537.66 | 427.4 | 385.86 | 321.28 | 182.73 |
Cash Growth | 25.31% | 25.80% | 10.77% | 20.10% | 75.83% | -11.00% |
Accounts Receivable | 32.2 | 29.53 | 52.37 | 38.29 | 169.96 | 44.24 |
Other Receivables | 5.79 | 3.01 | 0.41 | 5.37 | 31.91 | 93.17 |
Receivables | 37.99 | 32.55 | 52.78 | 43.66 | 201.87 | 137.4 |
Inventory | 50.88 | 59.78 | 41.05 | 58.97 | 45.55 | 33.61 |
Prepaid Expenses | - | 0.03 | 1.75 | - | - | 3.29 |
Other Current Assets | 17.13 | 3.66 | 4.63 | 1.19 | 6.3 | 5.14 |
Total Current Assets | 829.88 | 633.68 | 527.61 | 489.67 | 575.01 | 362.17 |
Property, Plant & Equipment | 320.68 | 331.3 | 344.63 | 349.15 | 364.85 | 378.96 |
Long-Term Investments | 33.39 | 3.53 | 3.62 | 42.57 | - | - |
Goodwill | 16.67 | 16.67 | 16.67 | 16.67 | 36.47 | 36.47 |
Other Intangible Assets | 20 | 19.2 | 20.7 | 25.91 | 31.1 | 37.25 |
Long-Term Deferred Tax Assets | 3.7 | 3.84 | 2 | 3.51 | 4.81 | 2.13 |
Long-Term Deferred Charges | - | - | - | - | 1.78 | 3.57 |
Other Long-Term Assets | 8.95 | 9.45 | 11.24 | 0.26 | 4.18 | 3.92 |
Total Assets | 1,233 | 1,018 | 926.47 | 927.74 | 1,018 | 824.47 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 210.17 | 105.83 | 103.51 | 106.04 | 127.01 | 17.2 |
Accrued Expenses | 30.13 | 27.8 | 18.98 | 14.71 | 27.23 | 18.56 |
Short-Term Debt | 55.39 | 11.26 | 22.82 | 11.01 | 50.05 | - |
Current Income Taxes Payable | 22.75 | 5.21 | 1.87 | 1.48 | 4.74 | 1.4 |
Current Unearned Revenue | 0.52 | 1.95 | 3.15 | 3.51 | 4.21 | 9.24 |
Other Current Liabilities | 64.63 | 44.62 | 24.78 | 34.33 | 48.67 | 52.94 |
Total Current Liabilities | 383.58 | 196.68 | 175.12 | 171.08 | 261.91 | 99.35 |
Long-Term Unearned Revenue | 4.49 | 4.97 | 5.78 | 6.6 | 4.43 | 5.02 |
Other Long-Term Liabilities | - | - | - | - | 1.86 | - |
Total Liabilities | 388.07 | 201.65 | 180.89 | 177.68 | 268.21 | 104.36 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 190.68 | 190.68 | 190.68 | 190.68 | 190.68 | 191.19 |
Additional Paid-In Capital | 260.06 | 232.64 | 232.66 | 232.66 | 232.68 | 234.49 |
Retained Earnings | 503.31 | 432.46 | 358.61 | 318.28 | 321.96 | 296.83 |
Treasury Stock | -117.07 | -48.15 | -50.03 | - | -0.02 | -5.12 |
Comprehensive Income & Other | 8.22 | 8.39 | 7.08 | 3.4 | -0.01 | -0 |
Total Common Equity | 845.19 | 816.02 | 739 | 745.02 | 745.29 | 717.39 |
Minority Interest | - | - | 6.57 | 5.04 | 4.7 | 2.72 |
Shareholders' Equity | 845.19 | 816.02 | 745.58 | 750.06 | 750 | 720.11 |
Total Liabilities & Equity | 1,233 | 1,018 | 926.47 | 927.74 | 1,018 | 824.47 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 55.39 | 11.26 | 22.82 | 11.01 | 50.05 | - |
Net Cash (Debt) | 668.49 | 526.41 | 404.58 | 374.85 | 271.23 | 182.73 |
Net Cash Growth | 21.34% | 30.11% | 7.93% | 38.20% | 48.44% | 10.53% |
Net Cash Per Share | 3.64 | 2.84 | 2.20 | 1.95 | 1.41 | 0.95 |
Filing Date Shares Outstanding | 186.13 | 190.07 | 183.47 | 190.68 | 190.68 | 191.19 |
Total Common Shares Outstanding | 186.13 | 190.07 | 183.47 | 190.68 | 190.68 | 191.19 |
Working Capital | 446.3 | 437 | 352.5 | 318.59 | 313.1 | 262.83 |
Book Value Per Share | 4.54 | 4.29 | 4.03 | 3.91 | 3.91 | 3.75 |
Tangible Book Value | 808.53 | 780.15 | 701.64 | 702.44 | 677.72 | 643.67 |
Tangible Book Value Per Share | 4.34 | 4.10 | 3.82 | 3.68 | 3.55 | 3.37 |
Buildings | - | 347.94 | 349.96 | 350.18 | 350.18 | 350.18 |
Machinery | - | 111.3 | 106.93 | 96.49 | 96.82 | 92.61 |
Construction In Progress | - | - | - | - | - | 2.41 |